Oncotartis, Inc.   Report issue

For profit Phase 1
Founded: Buffalo NY United States (2011)

Organization Overview

First Clinical Trial
2019
NCT03921879
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Oncotartis, Inc.